These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Topical administration of cyclosporin in psoriasis vulgaris]. Bunse T; Schulze HJ; Mahrle G Z Hautkr; 1990 Jun; 65(6):538, 541-2. PubMed ID: 2202163 [TBL] [Abstract][Full Text] [Related]
7. A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial. Jemec GB; Ganslandt C; Ortonne JP; Poulin Y; Burden AD; de Unamuno P; Berne B; Figueiredo A; Austad J J Am Acad Dermatol; 2008 Sep; 59(3):455-63. PubMed ID: 18694678 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of a betamethasone dipropionate topical glycol preparation in the management of severe psoriasis. Leer JA Clin Ther; 1980; 3(3):156-67. PubMed ID: 7006810 [TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study. Calcipotriol Study Group. Molin L; Cutler TP; Helander I; Nyfors B; Downes N Br J Dermatol; 1997 Jan; 136(1):89-93. PubMed ID: 9039301 [TBL] [Abstract][Full Text] [Related]
10. Profile of clinical efficacy and safety of topical tacalcitol. Leone G; Pacifico A Acta Biomed; 2005 Apr; 76(1):13-9. PubMed ID: 16116820 [TBL] [Abstract][Full Text] [Related]
11. Microcirculatory modifications of psoriatic lesions during topical therapy. Rosina P; Giovannini A; Gisondi P; Girolomoni G Skin Res Technol; 2009 May; 15(2):135-8. PubMed ID: 19622121 [TBL] [Abstract][Full Text] [Related]
12. In vitro compatibility of tazarotene with other topical treatments of psoriasis. Hecker D; Worsley J; Yueh G; Lebwohl M J Am Acad Dermatol; 2000 Jun; 42(6):1008-11. PubMed ID: 10827404 [TBL] [Abstract][Full Text] [Related]
13. Treatment of psoriasis with 6-aminonicotinamide. Zackheim HS Arch Dermatol; 1975 Jul; 111(7):880-2. PubMed ID: 125068 [TBL] [Abstract][Full Text] [Related]
14. The efficacy and safety of topically applied indigo naturalis ointment in patients with plaque-type psoriasis. Lin YK; Wong WR; Chang YC; Chang CJ; Tsay PK; Chang SC; Pang JH Dermatology; 2007; 214(2):155-61. PubMed ID: 17341866 [TBL] [Abstract][Full Text] [Related]
15. Treatment of psoriasis with topical sirolimus: preclinical development and a randomized, double-blind trial. Ormerod AD; Shah SA; Copeland P; Omar G; Winfield A Br J Dermatol; 2005 Apr; 152(4):758-64. PubMed ID: 15840110 [TBL] [Abstract][Full Text] [Related]
16. Scalp psoriasis: topical calcipotriol 50 micrograms/g/ml solution vs. betamethasone valerate 1% lotion. Duweb GA; Abuzariba O; Rahim M; al-Taweel M; Abdulla SA Int J Clin Pharmacol Res; 2000; 20(3-4):65-8. PubMed ID: 11314240 [TBL] [Abstract][Full Text] [Related]
18. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis. Austad J; Bjerke JR; Gjertsen BT; Helland S; Livden JK; Morken T; Mørk NJ J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961 [TBL] [Abstract][Full Text] [Related]
19. Fluticasone propionate in the treatment of inflammatory dermatoses. Chu AC; Munn S Br J Clin Pract; 1995; 49(3):131-3. PubMed ID: 7779663 [TBL] [Abstract][Full Text] [Related]
20. Additive effects of calcipotriol and cyclosporine A: from in vitro experiments to in vivo applications in the treatment of severe psoriasis. Bagot M; Grossman R; Pamphile R; Binderup L; Charue D; Revuz J; Dubertret L C R Acad Sci III; 1994 Mar; 317(3):282-6. PubMed ID: 7994616 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]